Literature DB >> 11488985

Cross-talk between pro-inflammatory transcription factors and glucocorticoids.

I M Adcock1, G Caramori.   

Abstract

Asthma is a chronic inflammatory disease of the airway that is characterized by cellular infiltration and activation. These processes are induced by overexpression of chemokines and cytokines, such as eotaxin, IL-1beta and GM-CSF. These mediators are downstream targets for the transcription factors activator protein-1 (AP-1) and nuclear factor-kappaB (NF-kappaB), which control the expression of most immunomodulatory genes and whose activity and expression are elevated in asthma. Glucocorticoids are the most effective anti-inflammatory drugs used in the treatment of chronic inflammatory diseases such as asthma. They act by binding to a specific glucocorticoid receptor (GR) that on activation translocates to the nucleus and either increases (transactivates) or decreases (transrepresses) the expression of responsive genes. Transrepression is the major mechanism of glucocorticoid action in inhibiting inflammatory gene expression. Thus, the ability of the transcription factors AP-1 and NF-kappaB to induce gene transcription is attenuated by GR. Although only 5-10% of asthmatic subjects are glucocorticoid-insensitive, these subjects account for over 50% of the health-care costs for asthma (> $6 billion per annum). Examining these patients also gives an insight into important aspects of glucocorticoid action in controlling inflammation and into the development of potential new drugs. Biochemical and genomic studies have indicated abnormal induction of the c-Jun N-terminal kinase (JNK) pathway in some of these patients. The ability of most patients to respond to dexamethasone with induction of histone acetylation correlated with nuclear translocation of GR. However, a subgroup of these patients had an inability to correctly interact with the basal transcription complex in spite of high levels of nuclear GR. This suggests that cross-talk between pro- and anti-inflammatory transcription factors may modulate activation of the transcriptional complex and thereby reduce steroid actions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11488985     DOI: 10.1046/j.1440-1711.2001.01025.x

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  68 in total

Review 1.  Management of asthma in adults: current therapy and future directions.

Authors:  R H Green; C E Brightling; I D Pavord; A J Wardlaw
Journal:  Postgrad Med J       Date:  2003-05       Impact factor: 2.401

2.  Acute exercise activates myocardial nuclear factor kappa B.

Authors:  Marko Balan; Marius Locke
Journal:  Cell Stress Chaperones       Date:  2010-08-06       Impact factor: 3.667

3.  Transforming growth factor-β impairs glucocorticoid activity in the A549 lung adenocarcinoma cell line.

Authors:  S Salem; T Harris; J S L Mok; M Y S Li; C R Keenan; M J Schuliga; A G Stewart
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 4.  The Role of the Fibroblast in Inflammatory Upper Airway Conditions.

Authors:  Stephen L Ball; Derek A Mann; Janet A Wilson; Andrew J Fisher
Journal:  Am J Pathol       Date:  2015-12-10       Impact factor: 4.307

Review 5.  Pathogen recognition and inflammatory signaling in innate immune defenses.

Authors:  Trine H Mogensen
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

6.  Amelioration of experimental colitis after short-term therapy with glucocorticoid and its relationship to the induction of different regulatory markers.

Authors:  Helioswilton Sales-Campos; Patrícia R de Souza; Paulo J Basso; Viviani Nardini; Angelica Silva; Fernanda Banquieri; Vanessa B F Alves; Javier E L Chica; Auro Nomizo; Cristina R B Cardoso
Journal:  Immunology       Date:  2016-10-07       Impact factor: 7.397

Review 7.  Neuroendocrine-immune interactions in rheumatoid arthritis: mechanisms of glucocorticoid resistance.

Authors:  Marni N Silverman; Esther M Sternberg
Journal:  Neuroimmunomodulation       Date:  2008-07-29       Impact factor: 2.492

8.  Induction of bone-marrow eosinophilia in mice submitted to surgery is dependent on stress-induced secretion of glucocorticoids.

Authors:  Pedro Xavier Elsas; Heitor A Paula Neto; Alessandra B Cheraim; Elisabeth S S Magalhães; Maria Theresa S Accioly; Vinicius F Carvalho; Patricia M R e Silva; B B Vargaftig; Fernando Q Cunha; Maria Ignez C Gaspar Elsas
Journal:  Br J Pharmacol       Date:  2004-09-20       Impact factor: 8.739

9.  A miniaturized glucocorticoid receptor translocation assay using enzymatic fragment complementation evaluated with qHTS.

Authors:  Ping Jun Zhu; Wei Zheng; Douglas S Auld; Ajit Jadhav; Ryan Macarthur; Keith R Olson; Kun Peng; Hyna Dotimas; Christopher P Austin; James Inglese
Journal:  Comb Chem High Throughput Screen       Date:  2008-08       Impact factor: 1.339

10.  Brain-specific homeobox factor as a target selector for glucocorticoid receptor in energy balance.

Authors:  Bora Lee; Sun-Gyun Kim; Juhee Kim; Kwan Yong Choi; Seunghee Lee; Soo-Kyung Lee; Jae W Lee
Journal:  Mol Cell Biol       Date:  2013-05-13       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.